Nationwide Evolution of Pediatric Endoscopic Retrograde Cholangiopancreatography Indications, Utilization, and

Monique T Barakat1, George Cholankeril2, Roberto Gugig3

  • 1Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Lucille Packard Children's Hospital at Stanford University Medical Centerr, Stanford, CA; Division of Gastroenterology and Hepatology, Stanford University Medical Center, Stanford, CA.

The Journal of Pediatrics
|November 16, 2020
PubMed

Insights

Pediatric endoscopic retrograde cholangiopancreatography (ERCP) utilization increased, with 13% of patients readmitted post-procedure. Risk factors for readmission included younger age, male sex, obesity, and liver transplant history.

Area of Science:

  • Gastroenterology
  • Pediatric Gastroenterology
  • Health Services Research

Background:

  • Pediatric endoscopic retrograde cholangiopancreatography (ERCP) is a crucial diagnostic and therapeutic tool.
  • Understanding national trends in its utilization and outcomes is vital for optimizing pediatric care.
  • Limited data exists on nationwide pediatric ERCP trends and associated readmission rates.

Purpose of the Study:

  • To analyze the trends in utilization and outcomes of pediatric ERCP in the United States.
  • To identify predictors of 30-day readmission following pediatric ERCP.
  • To examine patient and hospital characteristics associated with ERCP outcomes.

Main Methods:

  • Utilized the National Inpatient Sample (2005-2014) and National Readmission Database (2010-2014).
  • Identified pediatric hospitalizations (<20 years) undergoing ERCP.
  • Employed multivariate logistic regression to identify predictors of 30-day readmission.

Main Results:

  • 11,060 pediatric ERCPs were performed, predominantly therapeutic (85%) for biliary or pancreatitis indications.
  • Readmission rates were 13%, with higher odds in younger children (0-4 years), males, obese patients, and those with liver transplants.
  • Urban teaching and urban hospitals showed lower odds of prolonged length of stay compared to rural hospitals.

Conclusions:

  • This study provides comprehensive nationwide data on pediatric ERCP volume, outcomes, and readmission trends.
  • Identified key patient and hospital factors influencing pediatric ERCP outcomes.
  • Offers insights for improving management of pediatric pancreaticobiliary diseases and post-ERCP care.
Abstract